Headache Guide · Hormones · Lifestyle

Understanding migraine: causes, triggers, hormones and what the guideline recommends

Migraine is a neurological disease with a strong hereditary component, not something imagined and not a character trait. Some supposed triggers could already be warning signs of the attack. And for prevention there are more evidence-based options than pills alone.

SJ
Shukri Jarmoukli · Physician, Integrative Medicine · ViveCura Berlin
DGN and DMKG guideline 2025 Trigger or warning sign Cycle, aura and contraception 61 sources with DOI
Why I'm writing this

When it comes to migraine, I hear two sentences that both fall short. It's just a headache. Or: with the right powder it will go away. Neither does justice to a sensitive brain.

It starts with a flicker at the edge of your field of vision, in the middle of a meeting. A glittering arc that slowly expands until you can no longer read the numbers on the screen.

Or it starts on Saturday morning, finally the weekend. And that is exactly when it starts throbbing behind your right eye, and the day no longer belongs to you. Many people know this pattern: the darkened room, the nausea, the sound of the dishwasher that suddenly becomes unbearable.

I would like to offer you something other than another list of things to avoid: an understanding of what happens in your brain, an honest sorting of triggers, a close look at hormones, and what the guideline and studies show. With everything that is established, and everything that is still open.

Before you read on

Red flags: when a headache needs medical attention immediately or promptly

Call 112 immediately or go to the emergency department if you have:

  • a sudden, thunderclap headache, the worst of your life
  • new neurological deficits such as paralysis, speech problems, loss of vision, confusion or impaired consciousness
  • headache with fever and a stiff neck
  • headache after a fall or a head injury

See a doctor promptly if you have:

  • headaches that are occurring for the first time or have changed noticeably
  • a new headache from around the age of 50, especially at the temple or with jaw pain when chewing, among other reasons because of an inflammation of the blood vessels, giant cell arteritis; if visual disturbances occur, on the same day
  • an aura that appears for the first time after the age of 40, consists only of deficits such as a loss of visual field, or is unusually long or very short
  • headache triggered by coughing, straining or exertion, or strongly dependent on body position
  • new or changed headaches during pregnancy or after giving birth

If thoughts of suicide appear alongside the headaches, get help immediately. In Germany, the Telefonseelsorge crisis line is available around the clock and free of charge at 0800 111 0 111 and 0800 111 0 222 (these are German numbers). In acute danger, call 112 or go to the nearest emergency department. Outside Germany, please use your local emergency number.

Triptans, pain relievers, preventive treatment or a contraceptive method are not to be stopped, reduced or replaced on your own. Any change belongs in the hands of the doctor who prescribed them.

Basis: SNNOOP10 red flags (Do 2019), ACR/EULAR criteria for giant cell arteritis (2022), ICHD-3.

What to expect here

  • Filter, wave, CGRP: what happens in the brain
  • Telling aura and tension-type headache apart
  • Why food cravings could be a warning sign
  • Weekends, sleep, alcohol, weather
  • Falling estrogen, perimenopause, pregnancy
  • Aura and the pill: the stroke risk
  • Magnesium, riboflavin, Q10 and the guideline
  • Histamine, gut, weight, mental health
  • Prevention without pills
  • Acute treatment, overuse, migraine injection
RCT · Meta · Guideline randomized, pooled, consensus Human cohort, diary, survey, imaging Animal model only background for a hypothesis Lab not used as evidence here

What happens in your brain: a sensitive filter, a traveling wave and a messenger called CGRP

“It's just a headache.” People with migraine hear this sentence surprisingly often, sometimes even from themselves.

Research sees it differently. Migraine is considered a disorder of stimulus processing in the nervous system. A large review from 2017 ranked it at that time as the sixth most common cause of disability worldwide.

The mixing desk with overly sensitive faders

Imagine your brain as a mixing desk. Light, sounds, smells, hunger, tiredness and hormonal signals come in as separate tracks, and the desk blends them into a coherent overall picture. In migraine, some faders seem to be set more sensitively. A team around Goadsby describes migraine as a largely accepted, inherited tendency of the brain to lose control of its incoming sensory signals. That could explain why light is so hard to bear during an attack.

How strong the predisposition is can be seen in a genome analysis around Hautakangas with 102,084 people with migraine and 771,257 controls. It identified 123 risk regions, including genes for CGRP and for a serotonin receptor, in other words for targets of today's migraine medications. Genome analysis Migraine does not come down to a single gene, but to many small variants. You did not choose them.

The attack may begin before the pain

Many people sense hours in advance that something is coming. They yawn, feel irritable or tired, have food cravings or a stiff neck. Hunger, sleep, mood and alertness are timed by a small region in the diencephalon, the hypothalamus, which is also closely linked to the daily rhythm and the menstrual cycle.

Imaging, single case 30 days in the MRI scanner, three attacks

Schulte and May had one person with migraine undergo a functional MRI every morning for 30 days and captured three spontaneous, untreated attacks.

In the 24 hours before the pain began, the hypothalamic response to pain stimuli was altered, as was its connection to the brainstem. The authors suspect a possible pacemaker of the attacks here.

What this means for you: the attack could begin a day before the pain. This is explicitly a hypothesis from a single case, but it changes how we think about triggers.

Schulte LH, May A. Brain. 2016;139(Pt 7):1987-1993. PMID: 27190019 · DOI: 10.1093/brain/aww097 [Case, single-case imaging]

The aura: a wave in the stadium

In some people with migraine, at least some attacks come with an aura, usually a shimmering zigzag arc or a blind spot, sometimes tingling or difficulty finding words. Think of the wave in a sports stadium: one block stands up and sits down, the next one stands up, and behind the wave it goes quiet for a moment. The aura seems to arise in a similar way, as a slowly traveling wave of excitation across the cerebral cortex followed by suppression. Specialists call this cortical spreading depolarization.

A team around Hadjikhani made this wave visible in three people during a visual aura using functional MRI. It moved across the visual cortex at 3.5 plus or minus 1.1 millimeters per minute, matching the movement of the shimmer. 3 people How the wave relates to the pain is still open. Charles and Baca emphasize that animal models support the aura explanation, but considerable uncertainty remains. A team around Ferrari puts it this way: spreading depolarization probably causes the aura and may also trigger the pain.

The pain: the trigeminal nerve and CGRP

According to current understanding, the headache arises in the trigeminovascular system. The trigeminal nerve supplies the meninges and their blood vessels with pain fibers that, when activated, can release messengers, including CGRP. For a long time, migraine was considered a vascular disease. The review around Ferrari summarizes the current state differently: the widening of blood vessels is only an accompanying phenomenon. So the vessels react along with it, but they are probably not the engine.

Provocation, double-blind, 12 people CGRP as a trigger in an experiment

A team around Lassen gave twelve people with migraine without aura an infusion of CGRP or placebo in a double-blind crossover design. Three people were excluded.

In the following eleven hours, all evaluated participants had headaches after CGRP, and one person after placebo. In three people, the delayed headache after CGRP met the criteria for migraine.

What this means for you: CGRP can trigger headache in migraine. This is exactly where the newer medications act. The study is very small.

Lassen LH, Haderslev PA, Jacobsen VB et al. Cephalalgia. 2002;22(1):54-61. PMID: 11993614 · DOI: 10.1046/j.1468-2982.2002.00310.x [Provocation study, double-blind, n=12]
An attack in four phases

From yawning to the hangover day

  • Premonitory symptoms. Hours before: tiredness, yawning, difficulty concentrating, stiff neck, food cravings. The hypothalamus is suspected of playing a part.
  • Aura, if present. Each aura symptom typically lasts 5 to 60 minutes and is fully reversible.
  • Headache. Activation of the trigeminal nerve, release of CGRP, plus nausea and hypersensitivity to light and noise. Untreated, 4 to 72 hours.
  • Recovery. Exhaustion and poor concentration, for up to 48 hours.

Based on ICHD-3 and reviews of the pathophysiology. Not every attack goes through all phases, and the role of the hypothalamus is a well-founded but unproven assumption.

One further level particularly interests me as a physician working integratively: the idea that in migraine, the brain's energy reserve and its workload do not match. I will come back to this in the section on nutrients, with all its limitations.

For everyday life, this first means something unspectacular: a headache diary. The guideline places great value on documentation, and the international classification recommends a headache diary. Note your headache days, intensity, medications, premonitory symptoms, sleep and, for women, the day of the cycle.

Reframe

Migraine is not a sign of weakness. Behind it there may be a brain that perceives a great deal and whose filter can reach its limits at certain moments.

Once you understand that, you can stop fighting against yourself and start working with this brain.

And now you know why a migraine attack is more than a headache: a process that may begin in the diencephalon hours before the pain.

Recognizing migraine: phases, aura and the difference from tension-type headache

Is what you have actually migraine? Or is the pressing feeling in your head in the evening something else?

First the good news: the diagnosis usually requires neither blood tests nor an MRI. The guideline of the German Society of Neurology and the German Migraine and Headache Society states that the diagnosis is based on the medical history and an unremarkable neurological examination. Additional diagnostics, and imaging in particular, are necessary for headaches with an unusual clinical presentation. [Guideline]

According to the guideline, the 1-year prevalence of migraine is between 10 and 15 percent. It is most common between the ages of 20 and 50, and during this phase women are affected up to three times as often as men. The classification speaks of chronic migraine when headache occurs on at least 15 days per month for more than three months, with migraine features on at least 8 of those days.

The criteria in everyday language

The International Classification of Headache Disorders, ICHD-3, describes migraine without aura as follows: at least five attacks lasting 4 to 72 hours. In addition, at least two of four features: one-sided, pulsating, moderate to severe, aggravated by routine physical activity such as climbing stairs. And at least one of the following: nausea or vomiting, or sensitivity to light and noise.

In migraine with aura, the aura symptoms are fully reversible. They affect vision, sensation or speech, less often other functions. It is typical for a symptom to spread over at least five minutes, to last 5 to 60 minutes and for headache to follow within 60 minutes. Over 90 percent of people with aura have a visual aura in at least some attacks, and aura can also occur entirely without headache. As accompanying symptoms, the guideline lists loss of appetite almost always, nausea in 80 percent, vomiting in 30 percent, sensitivity to light in 60 percent and sensitivity to noise in 50 percent.

Electronic diary, 97 people Premonitory symptoms are a time window

A team around Giffin had people with known premonitory symptoms keep an electronic diary for three months. 97 provided usable data.

From 72 percent of the entries with premonitory symptoms, they correctly predicted the migraine. The most common were tiredness in 72 percent of attacks with warning signs, difficulty concentrating in 51 percent and a stiff neck in 50 percent.

What this means for you: premonitory symptoms can be a useful early signal for many people. The sample was selected, however, because only people who already knew their premonitory symptoms could take part.

Giffin NJ, Ruggiero L, Lipton RB et al. Neurology. 2003;60(6):935-940. PMID: 12654956 · DOI: 10.1212/01.wnl.0000052998.58526.a9 [Cohort, prospective diary study]

Migraine or tension-type headache?

Both are common, and they often occur together. ICHD-3 describes frequent episodic tension-type headache as something that often occurs together with migraine without aura, and recommends a headache diary to tell them apart.

FeatureMigraine without auraTension-type headache
Duration4 to 72 hours30 minutes to 7 days
Sideoften one-sidedusually both sides
Characterpulsatingpressing, not pulsating
Intensitymoderate to severemild to moderate
Physical activitymakes the pain worsedoes not make it worse
Nauseacommonnone
Light and noisehypersensitivity to bothat most one of them
Simplified from ICHD-3 (frequent episodic tension-type headache). For migraine, two of the four pain features are enough.

Two differential diagnoses only briefly, because they have their own articles. Iron deficiency can contribute to headaches and dizziness and belongs in the workup when symptoms fit, see Iron deficiency: headaches and dizziness. If you regularly wake up with a headache and snore loudly, think of a nighttime breathing disorder, described in Recognizing sleep apnea. And if the neck is a source of pain in its own right: Back and neck pain from a holistic perspective.

What I observe clinically

Many people who say they constantly have headaches only recognize a pattern once they have kept a diary for several weeks: two different types of headache, a clustering around the period, or a quiet rise in the number of days they take pain relievers. This is experience from my consultations, not a study finding.

Reframe

A migraine diagnosis does not need a blood test and usually does not need an MRI. It needs a good conversation, a neurological examination and your diary.

Imaging is important when headaches are unusual or change.

And now you know why the most important examination in migraine is often the one you prepare at home.

Trigger or warning sign? Stress, relief, sleep, meals, alcohol and weather

No red wine, no chocolate, no aged cheese, go to bed on time, never get hungry. And still the attack comes, on a day when you did everything right. That wears you down. And it raises a question: what if some of the suspects are not the culprits at all?

In Kelman's survey of 1,207 people from a headache clinic, stress was the most frequently named trigger, at 79.7 percent. This was followed by hormones in women at 65.1 percent, not eating at 57.3 percent and weather at 53.2 percent. The reference base for these percentages is not entirely clear in the abstract. Survey On top of that, triggers are highly personal. A team around Peris had 326 people keep a diary on 33 possible factors for 90 days. On average, four factors per person were associated with attacks, and in 85 percent of those with at least one association, the profile was unique. So general lists of things to avoid rarely fit you exactly.

Food cravings: cause or first witness?

The international headache classification explicitly lists cravings for certain foods among the premonitory symptoms, alongside repeated yawning and tiredness. If you reach for chocolate before an attack, the craving could already have been the beginning.

Provocation study, 53 people When the trigger matches the warning sign

A team around Karsan recorded what 53 people with migraine suspected as triggers and which premonitory symptoms they knew, and then induced attacks with a nitroglycerin infusion.

Those who named a skipped meal as a trigger strikingly often had spontaneous food cravings as a premonitory symptom. Similarly, light as a trigger and light sensitivity as a premonitory symptom went together.

What this means for you: some reported triggers such as light, noise, food and skipped meals can be early signs of the premonitory phase. A change of perspective, not a free pass for every skipped meal.

Karsan N, Bose P, Newman J, Goadsby PJ. J Neurol. 2021;268(5):1885-1893. PMID: 33399964 · DOI: 10.1007/s00415-020-10344-1 [Provocation study, n=53]

And the chocolate? A team around Marcus gave 63 women with chronic headaches either chocolate or carob in a double-blind design. Headaches did not occur more often after chocolate, not even in women who considered it their trigger. The study is old and small, but it fits the picture.

Why migraine comes on the weekend

Diary study, 17 people Not the stress, but its decline

A team around Lipton had people from a headache center keep an electronic diary for three months. 17 people provided sufficient data, with 110 attacks.

The level of stress was generally not associated with migraine. A drop in stress from one evening to the next, however, was associated with more frequent migraine onset in the following 6, 12 and 18 hours, with odds ratios of 1.5 to 1.9.

What this means for you: the sudden easing of tension appears to increase the risk. The study is small, but it gives weekend and vacation migraine a measurable trace.

Lipton RB, Buse DC, Hall CB et al. Neurology. 2014;82(16):1395-1401. PMID: 24670889 · DOI: 10.1212/WNL.0000000000000332 [Cohort, prospective diary study, n=17]

On the weekend, the rhythm also often shifts: getting up later, eating later, coffee later. Whether the change in rhythm, the drop in caffeine or the premonitory phase itself is decisive cannot be separated from data like these.

Sleep: fragmentation rather than hours

A team around Bertisch followed 98 adults with episodic migraine for six weeks with a diary and a motion sensor. Short sleep of 6.5 hours or less and poor sleep quality were not associated with migraine. Low sleep efficiency according to the diary, meaning a lot of time awake in bed, was associated with 39 percent higher odds of headache, though not on the day directly after the night, but on the day after that. For fragmented sleep, the motion sensor even showed lower odds on the directly following day. Cohort, 98 people So the data are inconsistent. That is why I would rather focus on regularity than on the pressure to reach a certain number of hours. How this can work without creating new stress is described in Putting sleep hygiene into practice, and why morning light can stabilize the internal clock in Chronobiology and the internal clock.

Alcohol: often suspected, rarely reliable

Online survey, 2,197 people Red wine fact check

A team around Onderwater surveyed 2,197 people with migraine from a Leiden research cohort about alcohol as a trigger.

35.6 percent named alcohol. Red wine, at 77.8 percent, was the most frequently named alcoholic trigger. However, it reliably triggered an attack in only 8.8 percent.

What this means for you: red wine is an often suspected but unreliable trigger. The authors see this as an indication against alcohol as a sole trigger and rather for a threshold that fluctuates from day to day.

Onderwater GLJ, van Oosterhout WPJ, Schoonman GG et al. Eur J Neurol. 2019;26(4):588-595. PMID: 30565341 · DOI: 10.1111/ene.13861 [Cross-sectional, online survey]

What alcohol can change in the digestive tract even in small amounts is described in Alcohol and the gut.

Weather: yes for some, predictable no

More than half of the people in Kelman's survey named the weather. Measured data are more cautious. A team around Hoffmann compared attacks with air pressure, humidity and temperature in 100 people over twelve months. A subgroup showed clear weather sensitivity, the pooled analysis of all participants showed no significant association, and an attack could not be predicted from weather data. An analysis around Mukamal with 7,054 people from the emergency department found heat to be a small factor for severe headaches, with an odds ratio of 1.075 per 5 degrees. In this analysis, lower air pressure increased the risk in people without a migraine diagnosis.

Caffeine, drinking and skipped meals

Caffeine cuts both ways. In small amounts it is part of some pain reliever combinations, while regular larger amounts can tend to sustain headaches. The guideline mentions a limit of 200 mg per day to avoid effects that promote chronification. This is a quote from the guideline, not a personal recommendation. More on coffee in Coffee, cortisol, adenosine and hormones.

On drinking, the guideline is honest: it recommends at least 1.5 liters per day, but reports a randomized trial in which drinking more did not change headache frequency. And skipped meals remain a special case, because hunger can be both a trigger and a warning sign. A steady meal rhythm is a reasonable starting point. I would only try strict fasting experiments with frequent migraine under medical supervision. Why food cravings arise is described in Food cravings: where they come from.

Two perspectives

Avoid triggers or learn to cope with them?

The common view: find your triggers and avoid them consistently. For individual, clearly reproducible triggers, this makes sense.

What the evidence adds: many suspected triggers could be premonitory symptoms, and the profiles are individual. The guideline describes a randomized trial with 127 participants in which “Learning to cope with triggers”, that is, gradually learning to deal with triggers, was superior to pure avoidance. [Guideline] A systematic review around Hindiyeh rated the overall evidence on diet and migraine as low, and a review around Seng emphasizes how differently stress, sleep, diet and physical activity are associated with attacks in each person. If you avoid more and more, you may risk your life becoming smaller without the attacks becoming less frequent.

What does this mean for you? Keep your diary with both, suspected triggers and premonitory symptoms. Pay attention to regular sleep and meals, on the weekend too, and make transitions gentler. The first day of your vacation does not have to start with sleeping in until noon.

Reframe

Not every suspect is the culprit. Sometimes it is already the first witness.

Food cravings before an attack may not be a failure of your discipline, but a signal that the attack has already begun. That can take guilt out of the equation and give you a time window.

And now you know why an ever longer list of things to avoid rarely gets you further, and why rhythm and an honest diary can reveal more.

Hormones: why the cycle, perimenopause and pregnancy change so much

You could set your watch by it. Two days before your period, at the latest on the first day of bleeding, it is there. And often more stubborn than the attacks in between.

In a US survey around Buse with 162,756 people aged twelve and over, 17.3 percent of women and 5.7 percent of men met the criteria for migraine. A review by Vetvik and MacGregor describes migraine as two to three times more common in women and names female sex hormones as an important factor, alongside genetic differences.

Not the height, but the speed of the slide

A team around MacGregor had 40 women with menstrual migraine who were not using hormonal contraception provide daily urine samples over three cycles. Attacks clustered in the late luteal and early follicular phase, when estrogen falls, and were less frequent in phases of rising estrogen. Cohort, 38 evaluable

SWAN cohort, 114 and 223 women The same hormones, a steeper decline

A team around Pavlović compared daily hormone levels in ovulatory cycles in 114 women with migraine and 223 women without migraine.

In the two days after the luteal peak, urinary estrogen levels fell more steeply in women with migraine: in absolute terms by 33.8 versus 23.1 pg/mgCr, in percentage terms by 40 versus 30 percent. There were no differences in peak or daily levels of estrogen, LH and FSH.

What this means for you: in this study, women with migraine did not have unusual hormone levels on average, their estrogen simply fell faster. Two slides of the same height, one of them steeper. A single hormone blood test cannot capture this speed.

Pavlović JM, Allshouse AA, Santoro NF et al. Neurology. 2016;87(1):49-56. PMID: 27251885 · DOI: 10.1212/WNL.0000000000002798 [Cohort, prospective, SWAN]

For clearly menstrual migraine, the guideline describes medical options, from time-limited prevention around the period to hormonal strategies in consultation with the gynecologist. These are decisions for the consultation room, not schemes to copy. How stress can play into female hormones is described in Cortisol, stress and female hormones.

Perimenopause and pregnancy

Many women find that their migraine changes in the years before their last period. A team around Martin analyzed data from 3,664 women with migraine aged 35 to 65. At least ten headache days per month were reported by 8.0 percent of premenopausal, 12.2 percent of perimenopausal and 12.0 percent of postmenopausal women. In the fully adjusted model, only perimenopause remained associated with an increased risk, with an odds ratio of 1.42. Cross-sectional A good reason to discuss prevention again during this phase. More in Perimenopause: recognizing the symptoms and Menopause and sleep disorders.

During pregnancy, on the other hand, many women experience a break. A team around Sances followed 49 pregnant women with migraine. In migraine without aura, it improved in 46.8 percent in the first, 83.0 percent in the second and 87.2 percent in the third trimester. In the first month after birth, it returned in 55.3 percent, and breastfeeding appeared to protect against this. Cohort, 49 women This small study allows no conclusion about aura. New or changed headaches during pregnancy and after giving birth should always be checked by a doctor, and medications here are exclusively a medical decision. The guideline states that mild attacks during pregnancy can be treated without medication, with shielding from stimuli and rest.

A closer look

Migraine with aura and estrogen-containing contraception

Relative risk. A meta-analysis around Schürks found a relative risk of ischemic stroke of 2.16 for migraine with aura and 1.23 for migraine without aura, not significant. Age under 45, smoking and oral contraceptives increased the risk further.

The combination. A case-control study around Champaloux examined women aged 15 to 49 with a first stroke in a US insurance claims database. The reference group was women without migraine and without combined hormonal contraception. Odds ratios: aura with combined contraception 6.1. Aura without combined contraception 2.7. No aura with combined contraception 1.8. No aura without combined contraception 2.2.

Absolute risk. The cumulative incidence of ischemic stroke in this database was 11 per 100,000 women over the period 2006 to 2012. A systematic review around Sheikh calls the evidence weak and the absolute risk low, and recommends an individual weighing of benefits and harms.

Two positions. The European Headache Federation and the European Society of Contraception suggest not prescribing combined hormonal contraceptives in women with aura (weak recommendation) and name non-hormonal or progestogen-only methods as the preferred option (strong recommendation, both with low quality of evidence). The German guideline states (quotes from the guideline translated from German) that estrogen-containing contraceptives are “not fundamentally contraindicated, provided that the other risk factors are controlled”. For aura with frequent attacks, “progestogens should be used for contraception”, and highly active migraine with aura combined with increased vascular risk is considered a contraindication for combined oral contraceptives. [Guideline]

  • The decision belongs in a gynecological or medical consultation.
  • Do not stop your contraception on your own. Without reliable protection, an unplanned pregnancy is possible, and a switch needs to be planned.
  • Tell your gynecologist that you have aura. A new aura after starting combined contraception should be discussed promptly.
  • Not smoking and knowing your blood pressure are particularly valuable here. According to the guideline, risk factors such as high blood pressure, smoking and elevated blood lipids must be treated.

Estrogen-free alternatives are compared in Hormone-free contraception: comparing the methods.

Beyond this, migraine is also a reason to take your blood vessels seriously. In the Nurses’ Health Study II with 115,541 women, migraine was associated over around 20 years with a higher risk of major cardiovascular events, with a hazard ratio of 1.50. These are observational data without a separate analysis by aura. I read this as an invitation to preventive care, not as fate.

And men?

In men, migraine is overlooked more often

Men are affected less often, but according to Vetvik and MacGregor, migraine is diagnosed too rarely in them. If you are a man and know recurring, pulsating attacks with nausea or sensitivity to light, you are entitled to ask whether it might be migraine. In the meta-analysis around Schürks, the stroke risk in men was 1.37 and not significant. Diagnosis and treatment follow the same rules.

What does this mean for you? Note the day of your cycle in your headache diary. After two or three months, it is often possible to see whether your attacks are linked to your period, and you have a basis for a conversation about targeted prevention. And if you have aura, mention it every time hormones are prescribed.

Reframe

Your hormones do not have to be broken. Your brain seems above all to react sensitively to the speed and direction of their change.

That shifts the question from “Which value is wrong?” to “How do I deal with transitions?”. And for transitions there are medical strategies.

And now you know why migraine before your period can be so punctual, and why a single hormone level does not explain it.

The energy-hungry brain: magnesium, riboflavin, Q10, and what remains open about histamine, the gut and weight

At the drugstore there is a shelf full of migraine combination products, and in forums someone swears by avoiding histamine, someone else by a gut cleanse. What holds up?

Mechanistically plausible, human studies thin: A review around Gross describes migraine as a possible adaptive response, conserved over the course of evolution, in people with a corresponding predisposition whose brain has a mismatch between energy reserve and workload. Imagine a high-performance engine with a small tank. The attack could be a kind of emergency brake that helps to restore the energy balance. The authors speak of growing evidence, much of it from clinical data. However, it is largely indirect, comes from small studies and partly from animal models, and two authors of the review, Schoenen and Sándor, are first authors of the riboflavin and the Q10 study in the table, respectively. Hypothesis with animal data

SubstanceStudyStudy dose (as reported in the study)Result
MagnesiumPeikert 1996, RCT, 81 people600 mg as trimagnesium dicitrateAttack frequency in weeks 9 to 12 minus 41.6 percent with magnesium, minus 15.8 percent with placebo. Diarrhea in 18.6 percent.
MagnesiumPfaffenrath 1996, RCT, 69 people10 mmol twice dailyResponders 28.6 percent with magnesium, 29.4 percent with placebo. Study stopped early. Soft stools or diarrhea in 45.7 versus 23.5 percent.
MagnesiumChiu 2016, meta-analysis, 10 oral RCTsvariedLower frequency and intensity (odds ratios 0.20 and 0.27). Some studies without adequate randomization.
Riboflavin (vitamin B2)Schoenen 1998, RCT, 55 people400 mgAt least 50 percent fewer headache days: 15 percent with placebo, 59 percent with riboflavin.
Coenzyme Q10Sándor 2005, RCT, 42 people3 × 100 mgAt least halved attack frequency: 14.4 percent with placebo, 47.6 percent with Q10.
Coenzyme Q10Sazali 2021, meta-analysis, 6 RCTs, 371 peoplevariedAttacks somewhat less frequent and shorter, severity not significantly reduced.
Combination of magnesium, B2 and Q10Gaul 2015, RCT, 130 peoplecombination productMigraine days from 6.2 to 4.4 with the product and from 6.2 to 5.2 with placebo, difference not significant. Migraine burden significantly lower.
All doses are study data and not a recommendation. The two riboflavin studies on which the guideline relies come from the same group of authors. According to the guideline, Q10 showed no superiority over placebo in children and adolescents in a double-blind study.

What the guideline says, and why it sounds contradictory. Chapter 4.2.5 states (translated from German): “Dietary supplements with efficacy in migraine prophylaxis include magnesium, butterbur, riboflavin and coenzyme Q10. However, the scientific evidence is low.” On magnesium: “Overall, magnesium is suitable for patients who do not wish to receive drug therapy with a medication approved for this purpose.” Chapter 11, by contrast, states: “Dietary supplements and probiotics are not effective in the prophylaxis of migraine.” Subsection 11.1, however, names riboflavin, magnesium and Q10 separately and states that for other natural substances efficacy is “less clearly established”. I deliberately place both passages side by side, because even the guideline does not sound consistent here. This is not a recommendation in the strict sense. [Guideline]

The patient information from IQWiG, the German Institute for Quality and Efficiency in Health Care, was more cautious in 2022, before the current guideline: due to a lack of meaningful research, it was not possible to judge whether these remedies protect against migraine.

Safety with dietary supplements
  • Magnesium can often cause diarrhea. If your kidney function is impaired, please do not take magnesium products without consulting a doctor.
  • Riboflavin turns urine an intense yellow. The guideline names this as a typical side effect.
  • Herbal does not mean harmless: according to the guideline, butterbur is no longer available as a medicinal product in Germany and Austria, and the guideline mentions extremely rare past cases of severe liver function disorders in this context.
  • Combination products often contain other substances. Vitamin B6, for example, can promote nerve damage (neuropathy) at high doses over longer periods.
  • No product replaces an assessment when red flags are present or a prevention recommended by your doctor.

If at all, I see nutrients as an accompanied trial over several months, with a diary and in consultation with a doctor. Which forms of magnesium exist and how well they are tolerated is covered in Which magnesium is best?, and coenzyme Q10 in Coenzyme Q10 and statins.

Histamine and DAO: a question, not a diagnosis

Thin evidence: A research group around Izquierdo-Casas measured the activity of the histamine-degrading enzyme DAO in 137 people with migraine and 61 without. With migraine it averaged 64.5, without migraine 91.9 HDU/ml. 87 percent of the migraine group were below the cut-off, but so were 44 percent of the people without migraine. In a follow-up study, 100 people with low DAO received the enzyme or placebo for one month. Attack duration fell from 6.14 to 4.76 hours with DAO and from 7.53 to 6.68 hours with placebo. There was no significant difference between the groups, even though the title of the study sounds more positive. The guideline makes no recommendation. How histamine intolerance is properly assessed is described in Histamine intolerance and DAO deficiency. small studies

Gut and diet: plausible, but weakly supported

Hypothesis: A review around Arzani describes associations between migraine and gastrointestinal diseases such as Helicobacter infection, irritable bowel syndrome and celiac disease. How the gut and the brain interact here, however, is not entirely clear. Celiac disease is something that can be concretely tested for, and according to this review a gluten-free diet can reduce migraine frequency in people with it. In a meta-analysis of three studies with 179 people, probiotics showed no significant effect on frequency or severity, with very high heterogeneity. The guideline considers low-sugar, low-fat and ketogenic diets possibly effective and calls the evidence for special diets weak overall. More on the axis between belly and head in The gut-brain axis and vagus nerve stimulation.

Weight: an association, not a question of blame

In a meta-analysis around Gelaye with 288,981 participants, the risk of migraine was 27 percent higher with obesity and 13 percent higher with underweight. Both persisted after further adjustment. In a large telephone survey around Bigal, obesity was associated mainly with chronic migraine, not with chronic tension-type headache. A meta-analysis around Di Vincenzo of ten mostly small studies found that weight loss in people with obesity was associated with fewer headache days, regardless of how much weight was lost. To me, this argues against numerical targets and for a look at physical activity, sleep and silent inflammation, described in Understanding weight holistically.

Mental health: taking it seriously without calling migraine psychological

In a cohort around Breslau, depression at baseline predicted new-onset migraine, with an odds ratio of 3.4. Conversely, migraine predicted new-onset depression, with an odds ratio of 5.8. This does not mean that migraine is psychological. It means that both sides deserve attention. Depression is a serious illness that deserves its own medical and psychotherapeutic treatment. The antidepressant amitriptyline is also used for migraine prevention. An antidepressant is never stopped on your own, because stopping abruptly carries its own risks, and any change belongs in the hands of the doctor who prescribed it. How sleep and mood are connected is described in Sleep and depression.

If you have thoughts of suicide, get help immediately. In Germany, the Telefonseelsorge crisis line is available around the clock and free of charge at 0800 111 0 111 and 0800 111 0 222 (these are German numbers). In acute danger, call 112 or go to the nearest emergency department. Outside Germany, please use your local emergency number.

Reframe

A nutrient is not a switch, and a hypothesis is not a diagnosis. Magnesium, riboflavin or Q10 can be a small building block if the rest of the house is standing.

If you want to look into histamine or the gut, do so with support and not at the expense of prevention whose benefit is better established.

And now you know why, when it comes to supplements, I neither dismiss nor promise, but place both passages of the guideline side by side.

Prevention without pills: endurance exercise, relaxation, biofeedback, behavioral therapy and acupuncture

Many people wish they did not have to take medication permanently. This wish is legitimate and belongs openly in the conversation with your doctor, not in going it alone. And the evidence here is better than many people think.

Established and anchored in the guideline: “Cognitive behavioral therapy is definitely recommended for the prophylaxis of migraine. It can be used instead of or in combination with drug prophylaxis.” Relaxation techniques and biofeedback are also recommended, with an average reduction in migraine frequency of 35 to 45 percent. “Regular aerobic endurance exercise is recommended for the prophylaxis of migraine.” Mindfulness can be recommended to improve quality of life. And: “Drug therapy shall be combined with behavioral therapy methods …” (all quotes translated from German) [Guideline]

RCT, 91 people Exercise, relaxation and a medication compared

A team around Varkey divided 91 adults with migraine into three groups for three months: endurance training (in the study, 40 minutes three times a week), a relaxation program or topiramate.

In the last month of treatment, attacks decreased by 0.93 with exercise, by 0.83 with relaxation and by 0.97 with topiramate. There was no difference between the groups. According to the guideline, side effects occurred only in the topiramate arm.

What this means for you: in this study, exercise and relaxation did not differ significantly from an established preventive medication, all with just under one attack fewer per month. That is modest, but honest. There was no placebo arm.

Varkey E, Cider A, Carlsson J, Linde M. Cephalalgia. 2011;31(14):1428-1438. PMID: 21890526 · DOI: 10.1177/0333102411419681 [RCT, n=91]

A meta-analysis around Lemmens of six studies found on average 0.6 fewer migraine days per month after endurance training, with moderate quality of evidence. A meta-analysis by Nestoriuc and Martin of 55 studies on biofeedback found a mean effect size of 0.58, which remained stable over an average of 17 months. And in a randomized trial around Wells, migraine days decreased by 1.6 per month with mindfulness training and by 2.0 with headache education, with no difference. Mindfulness training did, however, improve disability, quality of life and depression scores.

Why physical activity can set so much in motion at the cellular level is described in Movement as medicine. You can find breathing exercises as an easy entry point into relaxation in Breathing techniques for the nervous system, and if sleep problems play a part, in Treating sleep disorders holistically.

Both sides

Acupuncture: slightly better than sham, similar to medication

Cochrane review: A team around Linde pooled 22 studies with 4,985 participants. Compared with no acupuncture, headache frequency after treatment was at least halved in 41 percent with and 17 percent without acupuncture. Compared with sham acupuncture, the figures were 50 versus 41 percent, an effect the authors call small. Compared with preventive medications, the figures were 57 versus 46 percent after three months and 59 versus 54 percent after six months, although the difference after six months was not significant. Fewer people dropped out because of side effects with acupuncture than with the medications.

A carefully blinded study around Xu with 150 people with migraine without aura showed a measurable advantage for real acupuncture over sham needles.

The guideline considers the superiority over sham acupuncture to be contradictory and speaks of moderate, nonspecific effects. [Guideline] Both belong together.

The guideline uses clear words elsewhere: a daith piercing is “not advisable”, and for homeopathy there were “no effects beyond the placebo effect”. [Guideline]

Reframe

Non-drug does not automatically mean weaker. In the study around Varkey, exercise and relaxation did not differ significantly from a preventive medication, and according to the guideline side effects only occurred in the medication arm.

And the guideline does not see behavioral therapy as plan B, but as a firm partner of preventive medication.

And now you know why the question is not whether to choose pills or lifestyle, but which combination suits you.

What can help quickly, what medications can do and when pain relievers themselves cause headaches

The attack is here. You just want it to stop. So first the honest answer: for no home remedy is there evidence that it reliably stops a severe attack. Acute medications are the best studied, and according to the guideline their effectiveness is greater when they are taken early in the headache phase. This also applies to triptans. [Guideline]

Acute treatment at a glance, without doses

  • Mild to moderate attacks should, according to the guideline, first be treated with pain relievers such as acetylsalicylic acid, nonsteroidal anti-inflammatory drugs or the combination of acetylsalicylic acid, paracetamol and caffeine. A Cochrane review around Kirthi found that acetylsalicylic acid did not differ from sumatriptan at the lower study dose in terms of pain freedom and relief after two hours. An additional medication against nausea reduced nausea and vomiting.
  • Triptans should, according to the guideline, be used for severe headaches and for attacks that do not respond to pain relievers. A network meta-analysis around Karlsson with 137 studies and 89,445 participants found the best profiles for eletriptan, rizatriptan, sumatriptan and zolmitriptan, more effective than the newer drugs lasmiditan, rimegepant and ubrogepant. Caution is advised in people with high cardiovascular risk.
  • Newer acute medications from the gepant and ditan groups are, according to the guideline, mainly an option when pain relievers or triptans are not sufficient, are not tolerated or must not be taken. After lasmiditan, the guideline points out that you should not drive for 8 hours.
  • Opioids are, according to the guideline, not to be used in the treatment of acute migraine attacks.
  • Without medication, the guideline names shielding from stimuli and rest. Local cooling is experienced as pleasant, and in a randomized trial higher concentration menthol oils on the forehead and temples were superior to a low concentration comparison solution. External neurostimulation devices are also discussed in the guideline.

Clinical tradition without a study basis: coffee with lemon or warm foot baths. Some people find home remedies like these pleasant, but I am not aware of robust migraine studies on them. I would not sit out a severe attack with them when effective remedies are available.

When the pill itself becomes the problem

The pill that used to seem so reliable is something you now need almost every other day. And the headaches tend to become more frequent. This pattern has a name: headache due to overuse of pain or migraine medication.

According to the guideline, the threshold for triptans and combination pain relievers is at least 10 days of use per month, and for simple pain relievers at least 15 days of use. The international classification speaks of this headache when, in a pre-existing headache disorder, headache occurs on at least 15 days per month and the overuse has lasted for more than three months. A review around Diener gives a 1-year prevalence of 1 to 2 percent, more common in women and in people with depression, anxiety and other chronic pain. Imagine a smoke detector that becomes so sensitive from constant testing that it goes off as soon as you make toast.

RCT, 120 people Three ways out of overuse

A team around Carlsen assigned 120 people with medication overuse headache at the Danish Headache Center to three medically supervised strategies: withdrawal plus prevention, prevention without withdrawal, or withdrawal with optional prevention after two months.

Headache days per month decreased by 12.3 with withdrawal plus prevention, by 9.9 with prevention alone and by 8.5 with withdrawal alone. This difference between the three groups was not significant. The groups did differ significantly in the return to episodic headache (74.2, 60.0 and 41.7 percent) and in medication overuse headache, which was no longer detectable after six months in 96.8 percent, 74.3 percent and 88.9 percent.

What this means for you: all three supervised approaches could help, and for these two outcomes the combination performed best. This is medical work with a plan, not cold turkey withdrawal on your own.

Carlsen LN, Munksgaard SB, Nielsen M et al. JAMA Neurol. 2020;77(9):1069-1078. PMID: 32453406 · DOI: 10.1001/jamaneurol.2020.1179 [RCT, open-label, n=120]
Important with overuse

No withdrawal on your own and no withdrawal scheme from the internet. A medication break or a switch belongs under medical supervision, and with high consumption often together with headache specialists. Do not stop triptans, pain relievers or preventive treatment on your own. In your diary, count the days you take medication, not the pills, and talk to a doctor early if they increase. The guideline states that prevention with topiramate, onabotulinumtoxinA, a gepant or a CGRP antibody can be started even while overuse is ongoing.

Preventive medication and the migraine injection

For frequent attacks, attacks with pronounced symptoms or prolonged aura, the guideline says that drug prevention should be offered in addition to information and behavioral change. As effective, it names the beta blockers propranolol and metoprolol, the calcium antagonist flunarizine, the anticonvulsants valproic acid and topiramate, and the antidepressant amitriptyline. Topiramate is contraindicated during pregnancy and in women of childbearing age without highly effective contraception, and valproic acid must not be used in women of childbearing age. In migraine prophylaxis, according to the guideline, valproic acid is “off-label”, that is, outside its approved use. [Guideline]

CGRP antibodies, colloquially the migraine injection, target CGRP or its receptor. According to the guideline (as of 2025, chapter 4.10), the monoclonal antibodies eptinezumab, erenumab, fremanezumab and galcanezumab are approved in Germany for migraine prophylaxis in adults with at least 4 migraine days per month. The rates for at least halved migraine frequency after three to six months were between 30 and 62 percent, and with placebo between 17 and 38 percent. They are not to be used during pregnancy and breastfeeding, according to the guideline they should not be used in women without adequate contraception, and caution is required in vascular diseases such as coronary heart disease, stroke or Raynaud's syndrome. On cost coverage, the guideline, as of 2025, states (translated from German) that all CGRP antibodies in Germany are “fully reimbursable within the scope of their approval”, but that prescriptions may be subject to an economic efficiency review, and that when switching, “the differences in reimbursability with regard to previous therapies must be taken into account”. At the same time, the guideline describes that the Federal Joint Committee (G-BA) found an added benefit for erenumab, fremanezumab and galcanezumab only in certain subgroups, and it calls for careful documentation of migraine days and previous therapies. This is a statement from the guideline and not a promise of cost coverage. Whether the requirements are met in an individual case is clarified by the prescribing practice. The European Headache Federation recommends the antibodies for episodic and chronic migraine.

Gepants are small molecules that block the CGRP receptor. According to the guideline, rimegepant is “effective and approved in the prophylaxis of episodic migraine”, and according to the guideline the EMA granted European marketing authorization in April 2022, for prophylaxis in adults with at least 4 migraine attacks per month. The guideline describes atogepant as effective in episodic and chronic migraine. In the manufacturer-funded pivotal trial around Ailani, migraine days decreased by 3.7 to 4.2 days with atogepant and by 2.5 days with placebo, so the difference from placebo was 1.2 to 1.7 days. A network meta-analysis around Haghdoost found that all CGRP drugs studied except a low eptinezumab dose significantly reduced migraine days compared with placebo, with the higher response rates being significant for the injected or infused drugs, but not for oral administration. According to the guideline, onabotulinumtoxinA is only an option in chronic migraine.

What stands above all medications

Do not stop triptans, pain relievers or preventive treatment on your own, do not reduce them and do not replace them with dietary supplements. Any change belongs in the hands of the doctor who prescribed them. Medications during pregnancy and breastfeeding are always a medical decision.

Three invitations for the coming weeks

First: keep a headache diary with headache days, days you take medication, premonitory symptoms, sleep and, for women, the day of the cycle. After a few weeks, you will have a good basis for any conversation with a doctor.

Second: choose a form of regular endurance exercise or a learnable relaxation technique that fits your life and that you will stick with. What counts is not the perfect program, but the one you will still be doing a year from now.

Third: if attacks come more than occasionally or the days you take medication increase, talk to a doctor about prevention. Early, not only when the diary is full.

Reframe

Medications and lifestyle are not opponents. The guideline explicitly wants to see them combined.

Well-chosen prevention is not a failure of your self-care, and physical activity, relaxation and behavioral therapy are not a second-class substitute.

And now you know why the question of quick relief deserves an honest answer that begins with an early medication and continues with a plan for the days between attacks. If you would rather not sort this out on your own: below this article you will find the option to book an appointment.

Frequently asked questions about migraine

What can help quickly during a migraine attack?

Acute medications are the best studied, and according to the guideline their effectiveness is greater when they are taken early in the headache phase. According to the guideline, mild to moderate attacks should first be treated with pain relievers such as acetylsalicylic acid or nonsteroidal anti-inflammatory drugs, and severe attacks or attacks that do not respond with triptans. Rest, shielding yourself from stimuli and local cooling can complement this. Which medication suits you is something to clarify with your doctor.

Which home remedies can help with migraine?

According to the guideline, local cooling is experienced as pleasant, and in a randomized trial higher concentration menthol oil on the forehead and temples was superior to a low concentration comparison solution. Drinking more did not change headache frequency in a randomized trial. For many popular home remedies such as coffee with lemon or foot baths, there are no robust migraine studies. I would not sit out a severe attack with home remedies when effective medications are available.

Why do I get migraines on the weekend?

In a small diary study with 17 people, a drop in stress from one evening to the next was associated with 1.5 to 1.9 times higher odds of migraine onset in the following hours, while the level of stress in general was not associated with migraine. On top of that, sleep, meal and coffee times often shift on the weekend. Regularity and gentler transitions are therefore a sensible approach.

Can the weather trigger migraine?

For a subgroup of people, this appears to be the case. In a study of 100 people over twelve months, however, the pooled analysis of all participants showed no significant association, and attacks could not be predicted from weather data. In a large analysis of emergency department visits, heat was a small factor for severe headaches.

Is migraine with aura dangerous?

By definition, aura symptoms are fully reversible. In a meta-analysis, however, migraine with aura was associated with roughly double the relative risk of ischemic stroke, which remains low in absolute terms. A first aura after the age of 40, an aura consisting only of deficits, or an aura of unusual duration should be checked by a doctor promptly. Not smoking and knowing your blood pressure are particularly valuable.

Can I take the pill if I have migraine with aura?

That is a decision you make together with your gynecologist. The European Headache Federation and the European Society of Contraception prefer estrogen-free methods when aura is present. The German guideline does not consider estrogen-containing preparations fundamentally contraindicated when risk factors are controlled, but for aura with frequent attacks, according to the guideline, progestogens should be used. Do not stop your contraception on your own, because a switch needs to be planned.

Why do I get migraines before my period?

Attacks cluster in the phase when estrogen falls, that is, shortly before and at the start of the period. In one study, estrogen fell more steeply in women with migraine, with otherwise comparable hormone levels. For clearly menstrual migraine, the guideline describes medical prevention strategies that belong in a consultation with your doctor.

Can men get migraines too?

Yes. In a large US survey, 5.7 percent of men and 17.3 percent of women met the criteria for migraine. According to a review, migraine is diagnosed too rarely in men. Diagnosis and treatment follow the same rules.

Can magnesium help with migraine?

The studies are contradictory. One randomized trial with 81 people found a greater decrease in attacks than with placebo, another with 69 people found no difference. The guideline calls the evidence low and considers magnesium suitable for people who do not want drug therapy with a medication approved for this purpose. Diarrhea is common, and if your kidney function is impaired, taking it should be discussed with a doctor.

Does histamine have anything to do with migraine?

In one study, low activity of the histamine-degrading enzyme DAO was found in 87 percent of people with migraine, but also in 44 percent of people without migraine. A study with DAO supplementation showed no significant difference from placebo. This is a hypothesis, not a diagnosis, and the guideline makes no recommendation.

Are food cravings a migraine trigger?

The international headache classification counts cravings for certain foods among the premonitory symptoms of an attack. In one study, people who named skipped meals as a trigger strikingly often had food cravings as a premonitory symptom. And in a double-blind study, headaches did not occur more often after chocolate than after carob.

What is the migraine injection, and who is it an option for?

This refers to antibodies against CGRP or its receptor. According to the German guideline (as of 2025), eptinezumab, erenumab, fremanezumab and galcanezumab are approved in Germany for migraine prevention in adults with at least 4 migraine days per month, and the European Headache Federation recommends them for episodic and chronic migraine. They are not to be used during pregnancy and breastfeeding. Whether they suit you depends on previous treatments, other conditions and a medical assessment.

Can migraine pills themselves cause headaches?

Yes. According to the guideline, the threshold for triptans and combination pain relievers is at least 10 days of use per month, and for simple pain relievers at least 15. The way out belongs under medical supervision, often with a medication break and prevention. Do not stop anything on your own and do not start a withdrawal by yourself.

How do I tell migraine apart from tension-type headache?

Migraine is usually pulsating, moderate to severe, gets worse with physical activity and comes with nausea or sensitivity to light and noise. Tension-type headache tends to be pressing, on both sides, mild to moderate and without nausea. Both can occur in the same person, and a headache diary can help you tell them apart.

Where migraine connects with other topics

Migraine is linked to sleep, hormones, nutrients, physical activity and mood. Here are twelve paths that lead on from this article.

When headache comes with dizziness and exhaustion
Iron deficiency: headaches and dizziness

Why iron deficiency can contribute to headaches, dizziness and circulatory problems.

When you are thinking about magnesium
Which magnesium is best?

The forms compared, including tolerability. The migraine evidence is here, the guide to the forms is there.

When histamine is under suspicion
Histamine intolerance and DAO deficiency

How histamine intolerance is recognized and classified diagnostically.

When migraine changes during the transition years
Perimenopause: recognizing the symptoms

How to recognize the transition years and when they can begin.

When you have aura and want to talk about contraception
Hormone-free contraception compared

The methods without hormones compared, as preparation for the conversation with your gynecologist.

When hot flashes break up your sleep
Menopause and sleep disorders

Estrogen, progesterone and waking up at night, and what can help.

When your sleep is fragmented
Treating sleep disorders holistically

The map of causes behind disturbed sleep.

When you wake up with a headache in the morning
Recognizing sleep apnea

Snoring, pauses in breathing, daytime sleepiness: when a sleep study makes sense.

When coffee is friend and foe at the same time
Coffee, cortisol and adenosine

What caffeine has to do with cortisol, adenosine and hormones.

When you want to prevent attacks without pills
Movement as medicine

What regular physical activity can set in motion at the cellular level.

When weight is an issue, without blame
Understanding weight holistically

All the building blocks of body weight at a glance.

When your mood suffers too
Sleep and depression

How sleep and mood influence each other and why both deserve to be taken seriously.

SJ

Shukri Jarmoukli

Physician, Integrative Medicine · ViveCura Berlin

In my private practice, I work at the interface of conventional medicine, functional medicine and Clinical Psychoneuroimmunology. With migraine, I am interested in how rhythm, hormones, energy metabolism and the nervous system interact, and how good neurological treatment can be meaningfully combined with lifestyle.

This article does not replace medical advice and is explicitly not a guide to changing an existing treatment. It is meant to help you ask better questions at your next appointment.

ViveCura, Privatpraxis Shukri Jarmoukli, Skalitzer Straße 137, 10999 Berlin

Scientific sources

  1. Diener HC, Förderreuther S, Kropp P, Reuter U et al.; German Society of Neurology (Deutsche Gesellschaft für Neurologie), German Migraine and Headache Society (Deutsche Migräne- und Kopfschmerzgesellschaft). Therapie der Migräneattacke und Prophylaxe der Migräne (Treatment of migraine attacks and prophylaxis of migraine), S1 guideline, 2025. AWMF register number 030/057, version 7.1, valid until 7 August 2028. Online: dgn.org/leitlinien and register.awmf.org, accessed 16 September 2026. No DOI. [Guideline]
  2. Headache Classification Committee of the International Headache Society. The International Classification of Headache Disorders, 3rd edition. Cephalalgia. 2018;38(1):1-211. PMID: 29368949 · DOI: 10.1177/0333102417738202 [Classification]
  3. Sacco S, Merki-Feld GS, Ægidius KL et al. Hormonal contraceptives and risk of ischemic stroke in women with migraine: a consensus statement from the European Headache Federation (EHF) and the European Society of Contraception and Reproductive Health (ESC). J Headache Pain. 2017;18(1):108. PMID: 29086160 · DOI: 10.1186/s10194-017-0815-1 [Consensus Guideline, EHF and ESC]
  4. Sacco S, Amin FM, Ashina M et al. European Headache Federation guideline on the use of monoclonal antibodies targeting the calcitonin gene related peptide pathway for migraine prevention, 2022 update. J Headache Pain. 2022;23(1):67. PMID: 35690723 · DOI: 10.1186/s10194-022-01431-x [Guideline, EHF]
  5. Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG, German Institute for Quality and Efficiency in Health Care). Migränevorbeugung für Erwachsene (Migraine prevention for adults). gesundheitsinformation.de, updated 13 July 2022, accessed 16 September 2026. No DOI. [Patient information, IQWiG]
  6. Do TP, Remmers A, Schytz HW et al. Red and orange flags for secondary headaches in clinical practice: SNNOOP10 list. Neurology. 2019;92(3):134-144. PMID: 30587518 · DOI: 10.1212/WNL.0000000000006697 [Review, narrative]
  7. Ponte C, Grayson PC, Robson JC et al. 2022 American College of Rheumatology/EULAR classification criteria for giant cell arteritis. Ann Rheum Dis. 2022;81(12):1647-1653. PMID: 36351706 · DOI: 10.1136/ard-2022-223480 [Classification criteria]
  8. Ferrari MD, Goadsby PJ, Burstein R et al. Migraine. Nat Rev Dis Primers. 2022;8(1):2. PMID: 35027572 · DOI: 10.1038/s41572-021-00328-4 [Review]
  9. Goadsby PJ, Holland PR, Martins-Oliveira M et al. Pathophysiology of Migraine: A Disorder of Sensory Processing. Physiol Rev. 2017;97(2):553-622. PMID: 28179394 · DOI: 10.1152/physrev.00034.2015 [Review]
  10. Hadjikhani N, Sanchez Del Rio M, Wu O et al. Mechanisms of migraine aura revealed by functional MRI in human visual cortex. Proc Natl Acad Sci U S A. 2001;98(8):4687-4692. PMID: 11287655 · DOI: 10.1073/pnas.071582498 [Case, imaging, 3 people]
  11. Charles AC, Baca SM. Cortical spreading depression and migraine. Nat Rev Neurol. 2013;9(11):637-644. PMID: 24042483 · DOI: 10.1038/nrneurol.2013.192 [Review]
  12. Lassen LH, Haderslev PA, Jacobsen VB et al. CGRP may play a causative role in migraine. Cephalalgia. 2002;22(1):54-61. PMID: 11993614 · DOI: 10.1046/j.1468-2982.2002.00310.x [Provocation study, double-blind, n=12]
  13. Schulte LH, May A. The migraine generator revisited: continuous scanning of the migraine cycle over 30 days and three spontaneous attacks. Brain. 2016;139(Pt 7):1987-1993. PMID: 27190019 · DOI: 10.1093/brain/aww097 [Case, single-case imaging]
  14. Giffin NJ, Ruggiero L, Lipton RB et al. Premonitory symptoms in migraine: an electronic diary study. Neurology. 2003;60(6):935-940. PMID: 12654956 · DOI: 10.1212/01.wnl.0000052998.58526.a9 [Cohort, prospective diary study]
  15. Karsan N, Bose P, Newman J, Goadsby PJ. Are some patient-perceived migraine triggers simply early manifestations of the attack? J Neurol. 2021;268(5):1885-1893. PMID: 33399964 · DOI: 10.1007/s00415-020-10344-1 [Provocation study, n=53]
  16. Hautakangas H, Winsvold BS, Ruotsalainen SE et al. Genome-wide analysis of 102,084 migraine cases identifies 123 risk loci and subtype-specific risk alleles. Nat Genet. 2022;54(2):152-160. PMID: 35115687 · DOI: 10.1038/s41588-021-00990-0 [Meta-analysis, genome-wide]
  17. Buse DC, Loder EW, Gorman JA et al. Sex differences in the prevalence, symptoms, and associated features of migraine, probable migraine and other severe headache: results of the American Migraine Prevalence and Prevention (AMPP) Study. Headache. 2013;53(8):1278-1299. PMID: 23808666 · DOI: 10.1111/head.12150 [Cross-sectional, population-based]
  18. Vetvik KG, MacGregor EA. Sex differences in the epidemiology, clinical features, and pathophysiology of migraine. Lancet Neurol. 2017;16(1):76-87. PMID: 27836433 · DOI: 10.1016/S1474-4422(16)30293-9 [Review]
  19. Breslau N, Lipton RB, Stewart WF et al. Comorbidity of migraine and depression: investigating potential etiology and prognosis. Neurology. 2003;60(8):1308-1312. PMID: 12707434 · DOI: 10.1212/01.wnl.0000058907.41080.54 [Cohort, prospective]
  20. Kelman L. The triggers or precipitants of the acute migraine attack. Cephalalgia. 2007;27(5):394-402. PMID: 17403039 · DOI: 10.1111/j.1468-2982.2007.01303.x [Cross-sectional, headache clinic]
  21. Peris F, Donoghue S, Torres F et al. Towards improved migraine management: Determining potential trigger factors in individual patients. Cephalalgia. 2017;37(5):452-463. PMID: 27179352 · DOI: 10.1177/0333102416649761 [Cohort, prospective diary study, n=326]
  22. Lipton RB, Buse DC, Hall CB et al. Reduction in perceived stress as a migraine trigger: testing the “let-down headache” hypothesis. Neurology. 2014;82(16):1395-1401. PMID: 24670889 · DOI: 10.1212/WNL.0000000000000332 [Cohort, prospective diary study, n=17]
  23. Bertisch SM, Li W, Buettner C et al. Nightly sleep duration, fragmentation, and quality and daily risk of migraine. Neurology. 2020;94(5):e489-e496. PMID: 31843807 · DOI: 10.1212/WNL.0000000000008740 [Cohort, prospective, actigraphy]
  24. Onderwater GLJ, van Oosterhout WPJ, Schoonman GG et al. Alcoholic beverages as trigger factor and the effect on alcohol consumption behavior in patients with migraine. Eur J Neurol. 2019;26(4):588-595. PMID: 30565341 · DOI: 10.1111/ene.13861 [Cross-sectional, online survey]
  25. Marcus DA, Scharff L, Turk D, Gourley LM. A double-blind provocative study of chocolate as a trigger of headache. Cephalalgia. 1997;17(8):855-862. PMID: 9453274 · DOI: 10.1046/j.1468-2982.1997.1708855.x [Provocation study, double-blind, n=63]
  26. Hoffmann J, Schirra T, Lo H et al. The influence of weather on migraine: are migraine attacks predictable? Ann Clin Transl Neurol. 2015;2(1):22-28. PMID: 25642431 · DOI: 10.1002/acn3.139 [Cohort, prospective, n=100]
  27. Mukamal KJ, Wellenius GA, Suh HH, Mittleman MA. Weather and air pollution as triggers of severe headaches. Neurology. 2009;72(10):922-927. PMID: 19273827 · DOI: 10.1212/01.wnl.0000344152.56020.94 [Case-crossover study, n=7,054]
  28. Hindiyeh NA, Zhang N, Farrar M et al. The Role of Diet and Nutrition in Migraine Triggers and Treatment: A Systematic Literature Review. Headache. 2020;60(7):1300-1316. PMID: 32449944 · DOI: 10.1111/head.13836 [Systematic Review]
  29. Seng EK, Martin PR, Houle TT. Lifestyle factors and migraine. Lancet Neurol. 2022;21(10):911-921. PMID: 36115363 · DOI: 10.1016/S1474-4422(22)00211-3 [Review]
  30. MacGregor EA, Frith A, Ellis J et al. Incidence of migraine relative to menstrual cycle phases of rising and falling estrogen. Neurology. 2006;67(12):2154-2158. PMID: 16971700 · DOI: 10.1212/01.wnl.0000233888.18228.19 [Cohort, prospective]
  31. Pavlović JM, Allshouse AA, Santoro NF et al. Sex hormones in women with and without migraine: Evidence of migraine-specific hormone profiles. Neurology. 2016;87(1):49-56. PMID: 27251885 · DOI: 10.1212/WNL.0000000000002798 [Cohort, prospective, SWAN]
  32. Martin VT, Pavlovic J, Fanning KM et al. Perimenopause and Menopause Are Associated With High Frequency Headache in Women With Migraine: Results of the American Migraine Prevalence and Prevention Study. Headache. 2016;56(2):292-305. PMID: 26797693 · DOI: 10.1111/head.12763 [Cross-sectional, AMPP]
  33. Sances G, Granella F, Nappi RE et al. Course of migraine during pregnancy and postpartum: a prospective study. Cephalalgia. 2003;23(3):197-205. PMID: 12662187 · DOI: 10.1046/j.1468-2982.2003.00480.x [Cohort, prospective, n=49]
  34. Champaloux SW, Tepper NK, Monsour M et al. Use of combined hormonal contraceptives among women with migraines and risk of ischemic stroke. Am J Obstet Gynecol. 2017;216(5):489.e1-489.e7. PMID: 28034652 · DOI: 10.1016/j.ajog.2016.12.019 [Case-control study, nested]
  35. Sheikh HU, Pavlovic J, Loder E, Burch R. Risk of Stroke Associated With Use of Estrogen Containing Contraceptives in Women With Migraine: A Systematic Review. Headache. 2018;58(1):5-21. PMID: 29139115 · DOI: 10.1111/head.13229 [Systematic Review]
  36. Schürks M, Rist PM, Bigal ME et al. Migraine and cardiovascular disease: systematic review and meta-analysis. BMJ. 2009;339:b3914. PMID: 19861375 · DOI: 10.1136/bmj.b3914 [Meta-analysis, observational studies]
  37. Kurth T, Winter AC, Eliassen AH et al. Migraine and risk of cardiovascular disease in women: prospective cohort study. BMJ. 2016;353:i2610. PMID: 27247281 · DOI: 10.1136/bmj.i2610 [Cohort, prospective, n=115,541]
  38. Gross EC, Lisicki M, Fischer D et al. The metabolic face of migraine: from pathophysiology to treatment. Nat Rev Neurol. 2019;15(11):627-643. PMID: 31586135 · DOI: 10.1038/s41582-019-0255-4 [Review]
  39. Peikert A, Wilimzig C, Köhne-Volland R. Prophylaxis of migraine with oral magnesium: results from a prospective, multi-center, placebo-controlled and double-blind randomized study. Cephalalgia. 1996;16(4):257-263. PMID: 8792038 · DOI: 10.1046/j.1468-2982.1996.1604257.x [RCT, n=81]
  40. Pfaffenrath V, Wessely P, Meyer C et al. Magnesium in the prophylaxis of migraine: a double-blind placebo-controlled study. Cephalalgia. 1996;16(6):436-440. PMID: 8902254 · DOI: 10.1046/j.1468-2982.1996.1606436.x [RCT, stopped early, n=69]
  41. Chiu HY, Yeh TH, Huang YC, Chen PY. Effects of Intravenous and Oral Magnesium on Reducing Migraine: A Meta-analysis of Randomized Controlled Trials. Pain Physician. 2016;19(1):E97-112. PMID: 26752497 · no DOI [Meta-analysis, RCTs]
  42. Schoenen J, Jacquy J, Lenaerts M. Effectiveness of high-dose riboflavin in migraine prophylaxis. A randomized controlled trial. Neurology. 1998;50(2):466-470. PMID: 9484373 · DOI: 10.1212/wnl.50.2.466 [RCT, n=55]
  43. Sándor PS, Di Clemente L, Coppola G et al. Efficacy of coenzyme Q10 in migraine prophylaxis: a randomized controlled trial. Neurology. 2005;64(4):713-715. PMID: 15728298 · DOI: 10.1212/01.WNL.0000151975.03598.ED [RCT, n=42]
  44. Sazali S, Badrin S, Norhayati MN, Idris NS. Coenzyme Q10 supplementation for prophylaxis in adult patients with migraine: a meta-analysis. BMJ Open. 2021;11(1):e039358. PMID: 33402403 · DOI: 10.1136/bmjopen-2020-039358 [Meta-analysis, k=6 RCTs]
  45. Gaul C, Diener HC, Danesch U. Improvement of migraine symptoms with a proprietary supplement containing riboflavin, magnesium and Q10: a randomized, placebo-controlled, double-blind, multicenter trial. J Headache Pain. 2015;16:516. PMID: 25916335 · DOI: 10.1186/s10194-015-0516-6 [RCT, n=130]
  46. Izquierdo-Casas J, Comas-Basté O, Latorre-Moratalla ML et al. Low serum diamine oxidase (DAO) activity levels in patients with migraine. J Physiol Biochem. 2018;74(1):93-99. PMID: 28624934 · DOI: 10.1007/s13105-017-0571-3 [Cross-sectional, with control group]
  47. Izquierdo-Casas J, Comas-Basté O, Latorre-Moratalla ML et al. Diamine oxidase (DAO) supplement reduces headache in episodic migraine patients with DAO deficiency: A randomized double-blind trial. Clin Nutr. 2019;38(1):152-158. PMID: 29475774 · DOI: 10.1016/j.clnu.2018.01.013 [RCT, n=100]
  48. Arzani M, Jahromi SR, Ghorbani Z et al. Gut-brain Axis and migraine headache: a comprehensive review. J Headache Pain. 2020;21(1):15. PMID: 32054443 · DOI: 10.1186/s10194-020-1078-9 [Review, narrative]
  49. Parohan M, Djalali M, Sarraf P et al. Effect of probiotic supplementation on migraine prophylaxis: a systematic review and meta-analysis of randomized controlled trials. Nutr Neurosci. 2022;25(3):511-518. PMID: 32420827 · DOI: 10.1080/1028415X.2020.1764292 [Meta-analysis, k=3 RCTs]
  50. Gelaye B, Sacco S, Brown WJ et al. Body composition status and the risk of migraine: A meta-analysis. Neurology. 2017;88(19):1795-1804. PMID: 28404807 · DOI: 10.1212/WNL.0000000000003919 [Meta-analysis, observational studies]
  51. Bigal ME, Lipton RB. Obesity is a risk factor for transformed migraine but not chronic tension-type headache. Neurology. 2006;67(2):252-257. PMID: 16864817 · DOI: 10.1212/01.wnl.0000225052.35019.f9 [Cross-sectional, population-based]
  52. Di Vincenzo A, Beghetto M, Vettor R et al. Effects of Surgical and Non-surgical Weight Loss on Migraine Headache: a Systematic Review and Meta-Analysis. Obes Surg. 2020;30(6):2173-2185. PMID: 32008255 · DOI: 10.1007/s11695-020-04429-z [Meta-analysis, k=10]
  53. Diener HC, Dodick D, Evers S et al. Pathophysiology, prevention, and treatment of medication overuse headache. Lancet Neurol. 2019;18(9):891-902. PMID: 31174999 · DOI: 10.1016/S1474-4422(19)30146-2 [Review]
  54. Carlsen LN, Munksgaard SB, Nielsen M et al. Comparison of 3 Treatment Strategies for Medication Overuse Headache: A Randomized Clinical Trial. JAMA Neurol. 2020;77(9):1069-1078. PMID: 32453406 · DOI: 10.1001/jamaneurol.2020.1179 [RCT, open-label, n=120]
  55. Lemmens J, De Pauw J, Van Soom T et al. The effect of aerobic exercise on the number of migraine days, duration and pain intensity in migraine: a systematic literature review and meta-analysis. J Headache Pain. 2019;20(1):16. PMID: 30764753 · DOI: 10.1186/s10194-019-0961-8 [Meta-analysis, k=6]
  56. Varkey E, Cider A, Carlsson J, Linde M. Exercise as migraine prophylaxis: a randomized study using relaxation and topiramate as controls. Cephalalgia. 2011;31(14):1428-1438. PMID: 21890526 · DOI: 10.1177/0333102411419681 [RCT, n=91]
  57. Nestoriuc Y, Martin A. Efficacy of biofeedback for migraine: a meta-analysis. Pain. 2007;128(1-2):111-127. PMID: 17084028 · DOI: 10.1016/j.pain.2006.09.007 [Meta-analysis, k=55]
  58. Wells RE, O'Connell N, Pierce CR et al. Effectiveness of Mindfulness Meditation vs Headache Education for Adults With Migraine: A Randomized Clinical Trial. JAMA Intern Med. 2021;181(3):317-328. PMID: 33315046 · DOI: 10.1001/jamainternmed.2020.7090 [RCT, n=89]
  59. Linde K, Allais G, Brinkhaus B et al. Acupuncture for the prevention of episodic migraine. Cochrane Database Syst Rev. 2016;2016(6):CD001218. PMID: 27351677 · DOI: 10.1002/14651858.CD001218.pub3 [Systematic Review, Cochrane]
  60. Xu S, Yu L, Luo X et al. Manual acupuncture versus sham acupuncture and usual care for prophylaxis of episodic migraine without aura: multicentre, randomised clinical trial. BMJ. 2020;368:m697. PMID: 32213509 · DOI: 10.1136/bmj.m697 [RCT, n=150]
  61. Karlsson WK, Ostinelli EG, Zhuang ZA et al. Comparative effects of drug interventions for the acute management of migraine episodes in adults: systematic review and network meta-analysis. BMJ. 2024;386:e080107. PMID: 39293828 · DOI: 10.1136/bmj-2024-080107 [Meta-analysis, network]
  62. Kirthi V, Derry S, Moore RA. Aspirin with or without an antiemetic for acute migraine headaches in adults. Cochrane Database Syst Rev. 2013;2013(4):CD008041. PMID: 23633350 · DOI: 10.1002/14651858.CD008041.pub3 [Systematic Review, Cochrane]
  63. Haghdoost F, Puledda F, Garcia-Azorin D et al. Evaluating the efficacy of CGRP mAbs and gepants for the preventive treatment of migraine: A systematic review and network meta-analysis of phase 3 randomised controlled trials. Cephalalgia. 2023;43(4):3331024231159366. PMID: 36855951 · DOI: 10.1177/03331024231159366 [Meta-analysis, network]
  64. Ailani J, Lipton RB, Goadsby PJ et al. Atogepant for the Preventive Treatment of Migraine. N Engl J Med. 2021;385(8):695-706. PMID: 34407343 · DOI: 10.1056/NEJMoa2035908 [RCT, phase 3, manufacturer-funded]
Transparency on the evidence: where the data are thin
  1. The guideline is an S1 guideline, meaning expert consensus without grades of recommendation. The version cited is from 2025 (version 7.1). Its statements on dietary supplements are worded differently in two places. Both passages appear side by side in the text.
  2. The role of the hypothalamus is based on imaging in a single person, the aura wave on imaging in three people, and CGRP provocation on twelve people. These are mechanistic findings, not evidence for treatment.
  3. The energy metabolism hypothesis is based, according to the authors, on growing evidence, much of it from clinical data, which is, however, largely indirect and supplemented by animal models and small treatment studies. Two authors of the review are first authors of the cited riboflavin and Q10 studies.
  4. Magnesium, riboflavin and Q10 have been studied in small, partly old studies. One magnesium study was positive, one negative. The meta-analysis on magnesium has no DOI and includes studies without adequate randomization. The combination study missed significance for the frequency endpoint. All doses mentioned are study data.
  5. Histamine and DAO data come from two studies by one research group with a non-validated cut-off. The supplementation study lasted one month and showed no significant difference from placebo.
  6. Trigger data are based mainly on self-report, small diary studies and specialist clinics. The reference base for the percentages in Kelman's survey is not clear in the abstract.
  7. The stroke data are observational data with low quality of evidence, and the diagnoses in the case-control study come from billing codes. The figure of 11 per 100,000 is a cumulative incidence over 2006 to 2012 in this database, not an annual rate.
  8. The study on weight loss pools ten studies whose designs are not stated in the abstract. It allows no conclusion about cause and effect.
  9. The pivotal trial on atogepant was manufacturer-funded. Statements on approval and reimbursement in the text come exclusively from the German guideline as of 2025 and may have changed since then. On atogepant, I quote only the efficacy statement from the guideline passages reviewed. This article makes no statement about the approval status of atogepant, either positive or negative.
  10. Home remedies such as coffee with lemon or foot baths are labeled as clinical tradition, because no robust migraine studies on them were reviewed.
  11. What is deliberately not included here. No dosage recommendation, no withdrawal scheme, no treatment protocol, no product or device brands, and no advice to stop, reduce or replace triptans, pain relievers, preventive treatment, antidepressants or contraception. Nothing in any paragraph implies that a neurological, gynecological or psychotherapeutic assessment should be postponed.

Have questions or want to book an appointment?

We'd be happy to advise you personally at our practice.

Book appointment